|
O.D. Ostroumova, A.V. Dubinina, V.A. De, A.I. Kochetkov, V.B. Dashabylova, S.S. Eremina, M.V. Klepikova
On the issue of improving the safety of antithrombotic therapy in patients with atrial fibrillation and coronary heart disease receiving antithrombotic therapy
|
№14 / 2023
|
|
O.D. Ostroumova, I.Yu. Orlova, A.I. Kochetkov, O.A. Polyakova, A.I. Listratov, N.A. Shatalova, S.V. Batyukina
Structure of prescription of gastroprotective drugs in patients receiving direct oral anticoagulants: results of a multicenter cross-sectional pharmacoepidemiological study
|
№13 / 2022
|
|
D.I. Trukhan, D.S. Ivanova
Drug safety in real clinical practice: focus on protective therapy
|
№3 / 2022
|
|
D.I. Trukhan (1), E.L. Davydov (2)
The place and role of a therapist and general practitioner in the management of comorbid patients during the pandemic of the new coronavirus infection (COVID-19): an emphasis on non-specific prevention
|
№10 / 2021
|
|
D.I. Trukhan, D.S. Ivanova
Role and location of increased epithelial permeability syndrome in the development of cardiovascular and bronchopulum diseases: theoretical and practical aspects of application of rebamipide
|
№5 / 2021
|
|
O.D. Ostroumova (1, 2), A.I. Kochetkov (1), E.E. Pavleeva (3), O.V. Golovina (1), N.A. Arablinsky (4)
The relationship of cardiovascular disease with increased intestinal permeability: results from scientific and controlled clinical trials. Focus on the potential of rebamipide
|
№3 / 2021
|
|
L.M. Krums, O.V. Akhmadullina, S.V. Bykova, A.V. Babanova, S.R. Dbar, E.A. Sabelnikova, A.I. Parfenov
The use of rebamipide in the treatment of celiac disease as a possible example of the rapid achievement of complete remission
|
№2 / 2021
|
|
V.I. Simanenkov, N.V. Bakulina, Т.S. Fil, A.Kh. Khubieva
EVALUATION OF EFFICIENCY OF H. PYLORI ERADICATION IN CASE OF ADDITION OF CYTOPROTECTIVE PREPARATION REBAMIPIDE TO THE TREATMENT: RESULTS OF THE BASTION TRIAL
|
№s5-17 / 2017
|
|
T.A. Sivokhina, M.V. Kozhina
EXPERIENCE OF THE USE OF CYTOPROTECTOR REBAMIPIDE IN THE TREATMENT OF NSAID-INDUCED EROSIVE GASTROPATHY
|
№18 / 2017
|
Русский
